FDA OKs First Drug for Rett Syndrome ...Middle East

News by : (Medscape) -
Trofinetide (Daybue) is for adults and children aged 2 years and older with Rett syndrome, a rare, genetic neurodevelopmental disorder affecting mostly females. Medscape Medical News

Hence then, the article about fda oks first drug for rett syndrome was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs First Drug for Rett Syndrome )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار